INVESTIGATING THE OCCURRENCE AND IMPACT OF CYTOMEGALOVIRUS (CMV) IN KIDNEY TRANSPLANT RECIPIENTS AT REHMAN MEDICAL INSTITUTE, PESHAWAR: A COMPREHENSIVE ANALYSIS
Main Article Content
Keywords
CMV, Kidney Transplant, PCR
Abstract
Background: Cytomegalovirus (CMV) infection poses a significant challenge in kidney transplantation, potentially jeopardizing graft function and overall patient well-being. Therefore, our study aim is to identify frequency of CMV infection in kidney transplant patients.
Material And Methods: The study design used was a cross-sectional descriptive study. A total of 213 kidney transplant recipients were included in the study, chosen using systematic random sampling. Inclusion criteria encompassed individuals who had successfully undergone kidney transplantation at RMI hospital. Demographic and clinical data were obtained from medical records, covering factors such as age, gender, and transplant date. The prevalence of CMV infection was determined through laboratory tests, with a particular emphasis on Quantitative Polymerase Chain Reaction (PCR) assays capable of detecting CMV DNA in various materials.
Results: The results of the study demonstrated a notably higher prevalence of CMV infection among male kidney transplant patients. This disparity was especially prominent in the 18-35 years age group. Additionally, a significant prevalence of CMV was observed in patients aged 36-66 years.
Conclusion: The findings underscore the significance of gender and age in the context of CMV infection among kidney transplant patients. These insights prompt the need for tailored preventative and therapeutic strategies in the management of kidney transplant recipients at Rehman Medical Institute and potentially in similar contexts.
References
2) López-Oliva MO, Flores J, Madero R, Escuin F, Santana MJ, Bellón T, Selgas R, Jiménez C. Cytomegalovirus infection after kidney transplantation and long-term graft loss. Nefrología (English Edition). 2017 Sep 1;37(5):515-25.
3) Harvala H, Stewart C, Muller K, Burns S, Marson L, MacGilchrist A, Johannessen I. High risk of cytomegalovirus infection following solid organ transplantation despite prophylactic therapy. Journal of medical virology. 2013 May;85(5):893-8.
4) Lee YM, Kim YH, Han DJ, Park SK, Park JS, Sung H, Hong HL, Kim T, Kim SH, Choi SH, Kim YS. Cytomegalovirus infection after acute rejection therapy in seropositive kidney transplant recipients. Transplant Infectious Disease. 2014 Jun;16(3):397-402.
5) Komitopoulou A, Goussetis E, Oikonomopoulou C, Paisiou A, Kaisari K, Ioannidou E, Sipsas NV, Kosmidis H, Vessalas G, Peristeri I, Kitra V. Toxoplasma gondii: how fatal is it in pediatric allogeneic bone marrow transplantation setting?. Transplant Infectious Disease. 2020 Feb;22(1):e13226.
6) Kumar D, Chin‐Hong P, Kayler L, Wojciechowski D, Limaye AP, Osama Gaber A, Ball S, Mehta AK, Cooper M, Blanchard T, MacDougall J. A prospective multicenter observational study of cell‐mediated immunity as a predictor for cytomegalovirus infection in kidney transplant recipients. American Journal of Transplantation. 2019 Sep;19(9):2505-16.
7) Razonable RR, Humar AA. Cytomegalovirus in solid organ transplantation. American Journal of Transplantation. 2013 Mar 1;13:93-106.
8) Kotton CN. Migrating from universal to personalized prevention: predicting the risk of cytomegalovirus infection after organ transplantation. Transplantation. 2018 Nov 1;102(11):1787-8.
9) Saldan A, Forner G, Mengoli C, Gussetti N, Palù G, Abate D. Testing for cytomegalovirus in pregnancy. Journal of clinical microbiology. 2017 Mar;55(3):693-702.
10) Lønning K, Heldal K, Bernklev T, Brunborg C, Andersen MH, Von der Lippe N, Reisæter AV, Line PD, Hartmann A, Midtvedt K. Improved health-related quality of life in older kidney recipients 1 year after transplantation. Transplantation direct. 2018 Apr;4(4).
11) Leung J, Cannon MJ, Grosse SD, Bialek SR. Laboratory testing and diagnostic coding for cytomegalovirus among privately insured infants in the United States: a retrospective study using administrative claims data. BMC pediatrics. 2013 Dec;13(1):1-6.
12) Tariq Murad, Shayan Abid, Sadiq Umar, Hina Naz, Junaid Hameed, Maria Seemab, Eeman Amir et al. "UNRAVELLING THE RELATIONSHIP BETWEEN SMOKING AND THYROID STIMULATING HORMONE: HOW TOBACCO USE ALTER THYROID." Journal of Population Therapeutics and Clinical Pharmacology 31, no. 1 (2024): 142-148.
13) Singh N, Winston D, Razonable RR, Lyon III GM, Silveira FP, Wagener M, Limaye AP. LB21. Preemptive therapy (PET) vs. prophylaxis for prevention of cytomegalovirus (CMV) disease in high-risk donor seropositive/recipient seronegative (D+ R−) liver transplant recipients (LTR): a NIH-sponsored, randomized, controlled, multicenter trial. InOpen Forum Infectious Diseases 2018 Nov (Vol. 5, No. suppl_1, pp. S766-S766). US: Oxford University Press.
14) Abou-Jaoude M, El Hage S, Akiki D, Fadlallah M, Ghaith AK, Dib A. Cytomegalovirus infection in kidney transplant patients: Prevalence, risk factors, and impact on outcome–A local multicentre experience. Transplant Immunology. 2021 Dec 1;69:101473.
15) Kalluri, H. V. and K. L. Hardinger (2012). "Current state of renal transplant immunosuppression: Present and future." World journal of transplantation2(4): 51.
16) Tariq M, ur Rehman F, ur Rahman A, Hanif M, Umar S, Abid S. FREQUENCY OF HEMOGLOBINOPATHIES AND ITS RELATION WITH CONSANGUINITY AT TWO HEALTHCARE CENTERS OF PESHAWAR.